SCHEMBL17367121

SCHEMBL17367121

c1ccc(-n2c3cc4c(cc3c3c5ccccc5sc32)c2ccccc2n4-c2ccc3ccccc3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.42
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PMM2 O15305 1/20 0.37
MPI P34949 1/20 0.37
PHOSPHO1 Q8TCT1 1/20 0.37
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.33
F2 P00734 1/20 0.33
F10 P00742 1/20 0.33
PRSS1 P07477 1/20 0.33
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
PTPN1 P18031 1/20 0.31
PDE1B Q01064 1/20 0.30
PDE3A Q14432 1/20 0.30
PDE11A Q9HCR9 1/20 0.30
HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367119 0.89 KDM4E (0.43) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL18868360 0.88 KDM4E (0.39) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL17367132 0.87 KDM4E (0.43) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL18868344 0.86 ATM (0.44) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL23233630 0.85 KDM4E (0.58) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL17299993 0.85 ATM (0.43) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL18868249 0.84 KDM4E (0.38) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL17299670 0.84 KDM4E (0.38) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL17299666 0.84 KDM4E (0.38) ATMKDM4EL3MBTL1PMM2MPI
SCHEMBL24639816 0.84 ATM (0.45) ATMKDM4EL3MBTL1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 ATM 3202/4885KDM4E 3404/4885L3MBTL1 717/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 ATM 3202/4885KDM4E 3404/4885L3MBTL1 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.